Warning! GuruFocus detected
1 Severe warning sign
with NDOI.
Try a 7-Day Free Trial
to check it out.
What is a stock summary page? Click here for an overview.
Business Description
Endo Inc
NAICS : 325412
SIC : 2834
ISIN : US29290D1173
Description
Endo Inc is a diversified pharmaceutical company. It has four reportable business segments: (1) Branded Pharmaceuticals, (2) Sterile Injectables, (3) Generic Pharmaceuticals and (4) International Pharmaceuticals. Branded Pharmaceuticals segment includes a variety of branded products in the therapeutic areas of urology, orthopedics, etc. Sterile Injectables segment consists of branded sterile injectable products such as ADRENALIN, VASOSTRICT and APLISOL, among others. Generic Pharmaceuticals segment includes a product portfolio including patches, solid oral extended-release products, etc. Key revenue is generated from International Pharmaceuticals segment includes a variety of specialty pharmaceutical products, including OTC products, sold outside the U.S.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.16 | |||||
| Equity-to-Asset | 0.29 | |||||
| Debt-to-Equity | 1.98 | |||||
| Debt-to-EBITDA | 0.65 | |||||
| Interest Coverage | 0.34 | |||||
| Piotroski F-Score | N/A/9 | |||||
| Altman Z-Score | 3.52 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 21.27 | |||||
| 9-Day RSI | 24.34 | |||||
| 14-Day RSI | 30.74 | |||||
| 3-1 Month Momentum % | 19.94 | |||||
| 6-1 Month Momentum % | 8.66 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.87 | |||||
| Quick Ratio | 1.84 | |||||
| Cash Ratio | 0.75 | |||||
| Days Inventory | 176.26 | |||||
| Days Sales Outstanding | 95.81 | |||||
| Days Payable | 34.45 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 36.44 | |||||
| Operating Margin % | 1.41 | |||||
| Net Margin % | 245.59 | |||||
| FCF Margin % | -44.44 | |||||
| ROE % | Neg. Equity | |||||
| ROA % | 78.32 | |||||
| ROIC % | 0.57 | |||||
| ROC (Joel Greenblatt) % | 338.56 | |||||
| ROCE % | 86.99 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 0.43 | |||||
| PS Ratio | 1.12 | |||||
| PB Ratio | 1.55 | |||||
| EV-to-EBIT | 1.11 | |||||
| EV-to-EBITDA | 1.06 | |||||
| EV-to-Revenue | 2.68 | |||||
| EV-to-FCF | -6.03 | |||||
| Earnings Yield (Greenblatt) % | 90.09 | |||||
| FCF Yield % | -34.43 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:NDOI
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Endo Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 1,506.214 | ||
| EPS (TTM) ($) | 59.259 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | - | ||
| 14-Day RSI | 30.74 | ||
| 14-Day ATR ($) | 0.673357 | ||
| 20-Day SMA ($) | 27.48075 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range ($) | 22.5 - 31.4 | ||
| Shares Outstanding (Mil) | 76.21 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Endo Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Endo Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Endo Inc Frequently Asked Questions
What is Endo Inc(NDOI)'s stock price today?
The current price of NDOI is $25.51. The 52 week high of NDOI is $31.40 and 52 week low is $22.50.
When is next earnings date of Endo Inc(NDOI)?
The next earnings date of Endo Inc(NDOI) is .
Does Endo Inc(NDOI) pay dividends? If so, how much?
Endo Inc(NDOI) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers